
HIGHLIGHTS
EVENTS
Turkey, Kedrion supports the XVII International Congress on Hemophilia
The present and future role of Factor VIII at the center of the symposium supported by Kedrion
read moreEVENTS
Kedrion is one of the main sponsors of the National SISET Conference
The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science
read more-
EVENTS - 17-10-2016
Kedrion took part in the 17th ESID Meeting with 44 international guests
The conference focused on new insights into PIDs’ diagnosis and therapies
read more -
EVENTS - 23-09-2016
Pharmaceutical digitization: how to improve patient care and engagement
Kedrion Biopharma Advisor Prof. Albert Farrugia lectures at "The Future of Science" Conference in Venice, Italy
read more -
PLASMA & BIOTHERAPIES - 16-09-2016
Humanitarian Factor IX donation to Afghanistan
Kedrion Biopharma confirms its commitment to broaden access to therapies in developing Countries
read more -
PLASMA & BIOTHERAPIES - 13-09-2016
Kedrion and Kamada seek FDA approval of IgG as a post-exposure treatment
BLA has been submitted on September 1, 2016. Companies planning for decision from FDA in mid-2017
read more
Pages
For more information please contact: pressoffice@kedrion.com